Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biogaia Adr Class B BIOGY

Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics... see more

Recent & Breaking News (PINL:BIOGY)

Illumina to Provide Next-Generation Sequencing (NGS) Technologies to Quest Diagnostics

Business Wire January 9, 2014

Zymeworks Announces $15.0 Million Private Placement Financing to Advance Lead Programs into Clinical Trials

Business Wire January 9, 2014

Life Technologies to Provide Ion Torrent Sequencing Platform to Quest Diagnostics for Development of New Molecular Tests

PR Newswire January 9, 2014

Nextech Invest leads Blueprint Medicines US$ 25 Million Series B Financing

Thomson Reuters ONE January 9, 2014

The Allow Golden Rice Now! Campaign announces forums and public demonstrations against Greenpeace in nine European cities

PR Newswire January 9, 2014

Elephant Shark Genome Provides New Insights into Bone Formation and Adaptive Immunity in Humans

ACN Newswire January 8, 2014

GSK gains accelerated FDA approval for combination use of Mekinist® (trametinib) and Tafinlar® (dabrafenib)

PR Newswire January 8, 2014

New funding opportunity targets small U.S. companies developing biomedical products adaptable for use in space

PR Newswire January 8, 2014

ILiAD Biotechnologies, Inserm and Inserm Transfert SA, and Institut Pasteur de Lille Enter Scientific Collaboration and Worldwide License Agreements for Vaccine Technology

Business Wire January 8, 2014

Targeted Medical Pharma to Present at the Demy-Colton 2014 Biotech Showcase

Business Wire January 8, 2014

Imagine H2O Names Finalists in Global Competition for Water Startups

PR Newswire January 8, 2014

Quidel Announces Preliminary Revenue for Fourth Quarter 2013

Marketwired January 8, 2014

Vertex Announces Appointment of Jeffrey A. Chodakewitz, M.D., as Chief Medical Officer and Senior Vice President of Global Medicines Development

Business Wire January 8, 2014

Elephant shark genome raises understanding of cartilaginous fish

UPI January 8, 2014

Michael Baum, MD, Cancer Surgeon and Scientist, Joins Oncology Analytics' Distinguished Academic Advisory Board

Business Wire January 8, 2014

Global Metabolomics Market Report 2013 - Forecasts to 2017

PR Newswire January 8, 2014

Ovarian Cancer Vaccine Clinical Trial Extended to Two Additional Cancer Treatment Centers of America Hospitals

PR Newswire January 8, 2014

Bio-Inspired Glue Keeps Hearts Securely Sealed

PR Newswire January 8, 2014

Research and Markets: National Innovation Ecosystems: Healthcare, CMF, Energy Insights in United States, Germany & South Korea

Business Wire January 8, 2014

Global In Vitro Diagnostic Market Report 2013 - Forecast To 2017

PR Newswire January 8, 2014